Ansun raises $85M series A, plans Phase III for anti-viral

Ansun BioPharma Inc. (San Diego, Calif.) raised on May 14 a $85 million series

Read the full 142 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE